Endometrial atypical hyperplasia

Clinical trials for Endometrial atypical hyperplasia explained in plain language.

Never miss a new study

Get alerted when new Endometrial atypical hyperplasia trials appear

Sign up with your email to follow new studies for Endometrial atypical hyperplasia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1

Can a Weight-Loss drug and an IUD treat early uterine cancer without surgery?

Disease control Not yet recruiting

Researchers are testing whether a combination of semaglutide (Wegovy), a levonorgestrel-releasing intrauterine device (LNG-IUD), and a structured weight loss program can treat endometrial atypical hyperplasia or early-stage, grade 1 endometrioid endometrial cancer in women who wa…

Matched conditions: ENDOMETRIAL ATYPICAL HYPERPLASIA

Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control

Last updated Sep 17, 2026 00:00 UTC

Endometrial atypical hyperplasia

Get alerted when new Endometrial atypical hyperplasia trials appear

Can a Weight-Loss drug and an IUD treat early uterine cancer without surgery?